Li B - Search Results

1

[Construction and application of a lentiviral vector of single-chain variable fragment antibody against human hepatocyte growth factor receptor].

Chen Y, Guo J, Yin Y, Jiang M, Zhu H, Zhang G, Li B. Chen Y, et al. Among authors: li b. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Sep;30(9):960-3. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014. PMID: 25200159 Chinese.

2

CD89-mediated recruitment of macrophages via a bispecific antibody enhances anti-tumor efficacy.

Li B, Xu L, Pi C, Yin Y, Xie K, Tao F, Li R, Gu H, Fang J. Li B, et al. Among authors: li r. Oncoimmunology. 2017 Oct 12;7(1):e1380142. doi: 10.1080/2162402X.2017.1380142. eCollection 2017. Oncoimmunology. 2017. PMID: 29296544 Free PMC article.

3

Adaptive resistance in tumors to anti-PD-1 therapy through re-immunosuppression by upregulation of GPNMB expression.

Xu X, Xie K, Li B, Xu L, Huang L, Feng Y, Pi C, Zhang J, Huang T, Jiang M, Gu H, Fang J. Xu X, et al. Among authors: li b. Int Immunopharmacol. 2021 Dec;101(Pt B):108199. doi: 10.1016/j.intimp.2021.108199. Epub 2021 Oct 19. Int Immunopharmacol. 2021. PMID: 34673297

4

A Novel Anti-B7-H3 × Anti-CD3 Bispecific Antibody with Potent Antitumor Activity.

Feng Y, Xie K, Yin Y, Li B, Pi C, Xu X, Huang T, Zhang J, Wang B, Gu H, Fang J. Feng Y, et al. Among authors: li b. Life (Basel). 2022 Jan 21;12(2):157. doi: 10.3390/life12020157. Life (Basel). 2022. PMID: 35207448 Free PMC article.

5

Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade.

Xu L, Li B, Pi C, Zhu Z, Tao F, Xie K, Feng Y, Xu X, Yin Y, Gu H, Fang J. Xu L, et al. Among authors: li b. J Immunother Cancer. 2022 Dec;10(12):e005447. doi: 10.1136/jitc-2022-005447. J Immunother Cancer. 2022. PMID: 36460336 Free PMC article.

6

Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.

Xu L, Li B, Huang M, Xie K, Li D, Li Y, Gu H, Fang J. Xu L, et al. Among authors: li d, li y, li b. PLoS One. 2016 Jul 20;11(7):e0159426. doi: 10.1371/journal.pone.0159426. eCollection 2016. PLoS One. 2016. PMID: 27437939 Free PMC article.

7

Reversing PD-1 Resistance in B16F10 Cells and Recovering Tumour Immunity Using a COX2 Inhibitor.

Pi C, Jing P, Li B, Feng Y, Xu L, Xie K, Huang T, Xu X, Gu H, Fang J. Pi C, et al. Among authors: li b. Cancers (Basel). 2022 Aug 26;14(17):4134. doi: 10.3390/cancers14174134. Cancers (Basel). 2022. PMID: 36077671 Free PMC article.

8

Simultaneous exposure to FcγR and FcαR on monocytes and macrophages enhances antitumor activity in vivo.

Li B, Xu L, Tao F, Xie K, Wu Z, Li Y, Li J, Chen K, Pi C, Mendelsohn A, Larrick JW, Gu H, Fang J. Li B, et al. Among authors: li y, li j. Oncotarget. 2017 Jun 13;8(24):39356-39366. doi: 10.18632/oncotarget.17000. Oncotarget. 2017. PMID: 28454118 Free PMC article.

9

Neo-intline: integrated pipeline enables neoantigen design through the in-silico presentation of T-cell epitope.

Li B, Jing P, Zheng G, Pi C, Zhang L, Yin Z, Xu L, Qiu J, Gu H, Qiu T, Fang J. Li B, et al. Signal Transduct Target Ther. 2023 Oct 18;8(1):397. doi: 10.1038/s41392-023-01644-9. Signal Transduct Target Ther. 2023. PMID: 37848417 Free PMC article.

10

Circulating Tumor DNA Detection for Recurrence Monitoring of Stage I Non-Small Cell Lung Cancer Treated With Microwave Ablation.

Cheng L, Xu S, Wang YF, Li SW, Li B, Li XG. Cheng L, et al. Among authors: li b. Thorac Cancer. 2025 Jan;16(2):e15534. doi: 10.1111/1759-7714.15534. Thorac Cancer. 2025. PMID: 39825733

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,387 results

Search Page

Filters